Landmark independent study reports significantly improved task performance and satisfaction and lower pain compared with wheelchair use 

ReWalk users with chronic spinal cord injury were able to perform everyday kitchen and grooming activities while standing with a personal exoskeleton

Publication adds to clinical evidence supporting ReWalk as sales and national distribution access continue to expand

HUDSON, Mass. and YOKNEAM ILLIT, Israel, Sept. 15, 2026 (GLOBE NEWSWIRE) — Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today announced the publication of an independent, researcher-led peer-reviewed study demonstrating the potential for individuals with chronic spinal cord injury to use a personal exoskeleton to perform everyday activities while standing in their homes.

The study, “Beyond Walking: Exploring Functional Use of Exoskeletons in the Home Environment,” was published in the Internet Journal of Allied Health Sciences and Practice. The observational pilot study included 12 individuals with paraplegia due to chronic spinal cord injury and evaluated their ability to perform both activities of daily living (ADLs) and instrumental activities of daily living (IADLs) in their homes while using the ReWalk personal exoskeleton.

ADLs are fundamental personal-care activities, while IADLs are more complex activities required to function independently in daily life. In the study, all 12 participants successfully performed kitchen tasks while using the exoskeleton, and 10 of the 12 performed grooming tasks.

Researchers used established measures to assess participants before and after home exoskeleton use. The Canadian Occupational Performance Measure (COPM) evaluated participants’ perceived ability to perform the daily activities they identified as important, as well as their satisfaction with that performance. The Reintegration to Normal Living Index-modified (RNLI-M) assessed the importance of performing ADLs and IADLs while using the exoskeleton. Pain during exoskeleton use versus wheelchair use was evaluated using the Numeric Pain Rating Scale (NPRS). Researchers also assessed changes in bowel and bladder function and barriers to exoskeleton use.

The study reported:

  • Significant improvement in participants’ perceived ability to perform daily activities, as measured by COPM performance scores (P=.008);
  • Significant improvement in satisfaction with their performance of those activities, as measured by COPM satisfaction scores (P=.003);
  • Significant improvement on the RNLI-M measure assessing the importance of completing ADLs and IADLs using the exoskeleton (P=.04);
  • Significantly lower reported pain while using the exoskeleton compared with wheelchair use, as measured by the NPRS (P=.01);
  • All 12 participants performed kitchen tasks and 10 performed grooming tasks while using the exoskeleton; and
  • 8 out of 12 participants reported improvements in bowel and bladder function.

The researchers concluded that personal exoskeleton use at home may enable individuals with paraplegia to perform selected ADLs and IADLs while standing and was associated with improved perceived performance and satisfaction, lower pain during device use, and reported improvements in bowel and bladder function.

“This is a truly landmark first-of-its-kind study with findings that are critically important because they evaluate the ReWalk experience in terms that are highly relevant to the everyday lives of people with spinal cord injury—what they are able to do while standing in their own homes,” said Keith Rose, M.D., Chief Medical Officer of Lifeward. “The statistically significant improvements in task performance and satisfaction, with significantly lower reported pain compared with wheelchair use, provide meaningful additional evidence regarding the potential functional benefits of personal exoskeleton technology. The fact that every participant was able to perform kitchen activities while standing, and 10 of 12 were able to perform grooming activities, helps translate the clinical measures into practical outcomes that patients, clinicians, and payers can readily understand.”

“Peer-reviewed evidence of ReWalk’s real-world benefits can play an important role in expanding adoption,” said Josh Hexter, Interim Chief Executive Officer of Lifeward. “As we broaden access through our expanding distribution network, this evidence can help clinicians, patients, and payers understand ReWalk’s clinical value and support continued sales growth. We’re already seeing that recognition translate into coverage: Medicare Fee-for-Service and many national Medicare Advantage plans understand ReWalk’s clinical impact and are authorizing utilization for clinically appropriate patients.”

Excerpt from the study:

Several participants in this study volunteered anecdotal experiences with their personal exoskeleton use. Many described standing to complete functional tasks for the first time in years and remarked that they “felt normal”. Although these reports are anecdotal, they are consistent with the quantitative findings and suggest that exoskeleton use may offer meaningful nonpharmacologic benefits for some individuals. One participant with an incomplete SCI reported daily exoskeleton use for functional tasks. After several months he noted reduced leg atrophy and improved standing posture, suggesting regular exoskeleton use for functional tasks strengthened his innervated muscles. Another participant demonstrated that he could work on his truck engine while using the exoskeleton, a task he could not complete in his wheelchair or track chair. Several participants also reported changes in their medication regimens after incorporating regular exoskeleton use into their routines, including discontinuation of chronic opioid therapy, reductions in intrathecal baclofen dosage, and decreased need for antidepressant medications.

The publication comes as Lifeward continues to expand commercial access to ReWalk. ReWalk sales increased 13% year-over-year to $2.5 million in the second quarter of 2026, contributing to a 16% increase in total Lifeward revenue to $6.6 million. The Company is expanding its capital-efficient channel distribution strategy, including an August 2026 pilot with Ottobock Care, a leading U.S. mobility technology patient care organization with more than 50 patient clinics nationwide, designed to broaden access to ReWalk.

About Lifeward

Lifeward is a global innovator focused on advancing medical technologies and biomedical solutions that improve lives. The Company’s established portfolio includes market-leading neurorehabilitation technologies such as the ReWalk® Exoskeleton, AlterG® Anti-Gravity system, MyoCycle® FES System, and ReStore® Exo-Suit. These solutions span the continuum of care in physical rehabilitation and recovery, deploying the most advanced robotics and AI technologies to restore full health and quality of life to a broadening patient population. The Company is now executing a strategic evolution into a diversified biomedical company, expanding beyond rehabilitation and into high-value therapeutic platforms. This includes its Protein Oral Delivery (POD™) platform, designed to enable oral delivery of biologic drugs, with lead candidate ORMD-0801 (oral insulin) targeting a large and underserved diabetes market.

Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward mission and product portfolio, please visit GoLifeward.com.

Lifeward®, ReWalk®, ReStore® and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.

Forward-Looking Statements

In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, and Section 21E of the U.S. Securities Exchange Act of 1934. Such forward-looking statements may include projections regarding the Company’s future performance and other statements that are not statements of historical fact and, in some cases, may be identified by words like “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “should,” “would,” “seek” and similar terms or phrases. For example, when the Company discusses the potential benefits, expanded adoption, commercial access, clinical value and sales growth of ReWalk, and the Company’s distribution strategy, it is using forward-looking statements. The forward-looking statements contained in this press release are based on management’s current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. Important factors that could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements include, among others: management’s expectations, hopes, beliefs, intentions or strategies regarding the future including, without limitation, statements regarding: the future operations of Lifeward, including research and development activities; the nature, strategy and focus of Lifeward; Lifeward’s ability to successfully integrate Oratech Pharmaceuticals Ltd. into its organization and realize the anticipated benefits therefrom; anticipated clinical drug development activities and related timelines, and other clinical results; the sufficiency of post-transaction resources to support the advancement of Lifeward’s pipeline through certain milestones and the time period over which Lifeward’s post-transaction capital resources will be sufficient to fund its anticipated operations; unexpected costs, charges or expenses resulting from the strategic transaction; expected timing and results of the ORMD-0801 clinical trial; legislative, regulatory, political and economic developments; the acceptance of the ReWalk 7 Personal Exoskeleton by healthcare professionals and patients; uncertainties associated with future clinical trials and the clinical development process, the product development process and U.S. Food and Drug Administration regulatory submission review and approval process; the Company’s ability to have sufficient funds to meet certain future capital requirements, which could impair the Company’s efforts to develop and commercialize existing and new products; the Company’s ability to maintain and grow its reputation and the market acceptance of its products; the Company’s ability to achieve reimbursement from third-party payors, including CMS, for its products; the Company’s limited operating history and its ability to leverage its sales, marketing and training infrastructure; the Company’s expectations as to its clinical research program and clinical results; the Company’s expectations regarding future growth, including its ability to increase sales in its existing geographic markets and expand to new markets; the Company’s ability to continue to operate as a going concern; the Company’s ability to obtain certain components of its products from third-party suppliers and its continued access to its product manufacturers; the Company’s ability to navigate any difficulties associated with moving production of its AlterG Anti-Gravity Systems to a contract manufacturer and transitioning the manufacturing of its ReWalk products to its in-house manufacturer; the Company’s ability to improve its products and develop new products; the Company’s compliance with medical device reporting regulations to report adverse events involving the Company’s products, which could result in voluntary corrective actions or enforcement actions such as mandatory recalls, and the potential impact of such adverse events on the Company’s ability to market and sell its products; the Company’s ability to gain and maintain regulatory approvals; the Company’s ability to maintain adequate protection of its intellectual property and to avoid violation of the intellectual property rights of others; the risk of a cybersecurity attack or breach of the Company’s IT systems significantly disrupting its business operations; the Company’s ability to use effectively the proceeds of its offerings of securities; and other factors discussed under the heading “Risk Factors” in the Company’s annual report on Form 10-K, as amended, for the year ended December 31, 2025 filed with the Securities and Exchange Commission (SEC) and other documents subsequently filed with or furnished to the SEC. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause the Company’s actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for the Company to predict all of them. Except as required by law, the Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Contact:
Almog Adar
Chief Financial Officer
Lifeward

E: media@golifeward.com
E: ir@golifeward.com

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

VANCOUVER, British Columbia, Sept. 15, 2026 (GLOBE NEWSWIRE) — Doman Building Materials Group Ltd. (“Doman” or “the Company”) (TSX: DBM) is pleased to announce that its board of directors has declared a dividend for the 66th consecutive quarter, which will be paid on October 15, 2026, to shareholders of record on September 29, 2026, of $0.14 per share.

About Doman Building Materials Group Ltd.

Founded in 1989, Doman is headquartered in Vancouver, British Columbia, and trades on the Toronto Stock Exchange under the symbol DBM.

As Canada’s premier national distributor in the building materials and related products sector, Doman operates several distinct divisions with multiple treating plants, planing and specialty facilities and distribution centres coast-to-coast in all major cities across Canada and coast-to-coast across the United States.

Strategically located across Canada, Doman Building Materials Canada operates distribution centres coast-to-coast, and Doman Treated Wood Canada operates multiple treating plants near major cities. In the United States, headquartered in Dallas, Texas, Doman Lumber operates 21 treating plants, two specialty planing mills and five specialty sawmills located in nine states, distributing, producing and treating lumber, fencing and building material servicing the central U.S.; Doman Tucker Lumber operates three treating plants, specialty sawmilling operations and a captive trucking fleet serving the U.S. east coast; Doman Building Materials USA and Doman Treated Wood USA serve the U.S. west coast with multiple locations in California and Oregon; and in the state of Hawaii the Honsador Building Products Group services 15 locations across all the islands.

For additional information on Doman Building Materials Group Ltd., please refer to the Company’s filings on SEDAR+ and the Company’s website www.domanbm.com.

For further information regarding Doman please contact:

Ali Mahdavi
Investor Relations
416-962-3300
ali.mahdavi@domanbm.com

Certain statements in this press release may constitute “forward-looking” statements. When used in this press release, forward-looking statements often but not always, can be identified by the use of forward-looking words such as, including but not limited to, “may”, “will”, “would”, “should”, “expect”, “believe”, “plan”, “intend”, “anticipate”, “predict”, “remain”, “estimate”, “potential”, “forecast”, “budget”, “schedule”, “continue”, “could”, “might”, “project”, “targeting”, “future” and other similar terminology or the negative or inverse of such words or terminology. Forward-looking information in this news release includes, without limitation, statements with respect to: the ultimate impact (express or implied) of: a) fluctuations in commodity and construction materials pricing; b) the performance of recently acquired businesses; c) the performance of the Canadian and US economies; and d) the impact of COVID-19 on the Company’s operational and financial results and on consumer behaviour and economic activity, including but not limited to the second quarter and balance of 2026 results. These forward-looking statements reflect the current expectations of Doman’s management regarding future events and operating performance, but involve other known and unknown or unpredictable risks, uncertainties and other factors which may cause the actual results, performance or achievements of Doman, including but not limited, to sales, earnings, cash flow from operations, EBITDA generated, dividends generated or paid by Doman, including whether at the rate as of the date hereof or some other dividend rate in the future which may be lower than either of the preceding rates discussed therein, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements should therefore be construed in the light of such factors. Actual events could differ materially from those projected herein and depend on a number of factors and risks. These factors and risks include but are not limited to those set out in the Company’s annual information form dated March 31, 2026, and other public filings on the Canadian Securities Administrator’s website at www.sedarplus.ca. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. In addition, a number of material factors or assumptions were utilized or applied in making the forward-looking statements, and may include, but are not limited to, assumptions regarding the performance of the Canadian and U.S. economies, the relative stability of or level of interest rates, exchange rates, volatility of commodity prices, availability or more limited availability of access to equity and debt capital markets to fund, at acceptable costs, Doman’s future growth plans, the implementation and success of the integration of Doman’s acquisitions and customer and supplier retention, the ability of Doman to refinance its debts as they mature, the Canadian and United States housing and building materials markets; the direct and indirect effect of the U.S. housing market and economy; impacts of changes in international trade policies including tariffs on the Company, its suppliers, customers, cost of goods, sales pricing and the overall economic environment; post-acquisition operation of a business; exchange rate fluctuations between the Canadian and US dollar; retention of key personnel; Doman’s ability to sustain its level of sales and earnings margins; Doman’s ability to grow its business long term and to manage its growth; Doman’s management information systems upon which it is dependent are not impaired or compromised by breaches of Doman’s cybersecurity; Doman’s insurance is sufficient to cover losses that may occur as a result of its operations; international trade and tariff risks, political risks, the amount of Doman’s cash flow from operations; tax laws; and the extent of Doman’s future acquisitions and capital spending requirements or planning as well as the general level of economic activity, in Canada and the U.S., and abroad, discretionary spending and unemployment levels; the effect of general economic conditions, including market demand for Doman’s products, and prices for such products; the effect of forestry, land use, environmental and other governmental regulations; the risk of losses from fires, floods and other natural disasters and unemployment levels; social and governance risks do not adversely affect the Company’s reputation and shareholder, employee, customer, supplier or third party relationships; climate change does not adversely affect the Company’s business and/or damage its reputation; and the Company is not adversely impacted by disruptive technologies or competitors deploying same. There is a risk that some or all of these assumptions may prove to be incorrect. These and other factors could cause or contribute to actual results differing materially from those contemplated by forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements or information. These forward-looking statements speak only as of the date of this press release. We caution that the foregoing factors that may affect future results are not exhaustive. When relying on our forward-looking statements to make decisions with respect to Doman, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Neither Doman nor any of its associates or directors, officers, partners, affiliates, or advisers, provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in these communications will actually occur. You are cautioned not to place undue reliance on these forward-looking statements. Except as required by applicable securities laws and legal or regulatory obligations, Doman is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Leadership Transition Expected to Include New Members of Leadership Team and Board of Directors as Company in Connection With Strategic Repositioning

Fort Lauderdale, FL, Sept. 15, 2026 (GLOBE NEWSWIRE) — Algorhythm Holdings, Inc. (the “Company”) (NASDAQ: RIME) – a leading AI technology company, today announced a planned leadership transition in connection with the Company’s previously announced evaluation of strategic alternatives and a corporate repositioning.

As part of the transition, the Company dismissed Gary Atkinson as Chief Executive Officer of the Company following approximately 20 years of service to the Company. Mr. Atkinson also resigned from the Company’s Board of Directors.

The leadership transition occurred in connection with the completion of a corporate transaction that resulted in the appointment of a new Chief Executive Officer, additional members of the Board of Directors and a significant change in the Company’s operating focus.

“I want to take this opportunity to thank the many employees, business partners, customers and shareholders who have supported the Company throughout my time here,” said Gary Atkinson. “I am proud of what our team has accomplished together and believe we have positioned Algorhythm for an exciting new chapter.”

“This transition was part of a deliberate process by the Company to position itself for its next phase of growth,” continued Atkinson. “I am excited about the opportunities being pursued by the Company and believe the new leadership team brings a compelling vision for its future. As a continuing shareholder, I look forward to watching that strategy take shape in the coming weeks and months.”

The Company’s Board of Directors has been evaluating strategic alternatives designed to strengthen the Company’s financial and operating profile and enhance long-term shareholder value. As part of that process, the Company was evaluating an proposed acquisition involving a high-growth, revenue-generating, EBITDA-positive business operating in the energy space.

The Company will provide additional information in the near future regarding the transaction, new leadership team and future strategic direction of the Company.

About Algorhythm Holdings

Algorhythm Holdings, Inc. is a leading AI technology company that owns and operates SemiCab. Since 2020, SemiCab has enabled major retailers, brands and transportation providers to address common supply-chain problems globally. Its AI-enabled, cloud-based Collaborative Transportation Platform achieves the scalability required to predict and optimize millions of loads and hundreds of thousands of trucks. SemiCab uses real-time data from API-based load tendering and pre-built integrations with TMS and ELD partners to orchestrate collaboration across manufacturers, retailers, distributors, and their carriers. SemiCab uses AI/ML predictions and advanced predictive optimization models to enable fully loaded round trips. With SemiCab’s AI platform, shippers pay less and carriers make more without having to change a thing. For additional information, please go to: http://www.semicab.com.

Investor Relations Contact
Brendan Hopkins
407-645-5295
investors@algoholdings.com
www.algoholdings.com

Media Contact
FischTank PR
Algorhythm@fischtankpr.com

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any statement that is not historical in nature is a forward-looking statement and may be identified by the use of words and phrases such as “expects,” “anticipates,” “believes,” “will,” “will likely result,” “will continue,” “plans to,” “potential,” “promising,” and similar expressions. These statements are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including the risk factors described from time to time in Algorhythm’s reports to the SEC, including, without limitation Algorhythm’s Annual Report on Form 10-K for the year ended December 31, 2025. You should not place undue reliance on any forward-looking statement, each of which applies only as of the date of this press release. Except as required by law, we undertake no obligation to update or revise publicly any of the forward-looking statements after the date of this press release to conform our statements to actual results or changed expectations, or as a result of new information, future events or otherwise.

Modelled conductive responses are distributed along more than nine hundred (900) metres of the mapped Alps-Alturas shear corridor

VANCOUVER, British Columbia, Sept. 15, 2026 (GLOBE NEWSWIRE) — Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | OTCQB: MXMGF | FRA: R7V) is pleased to announce results from a first-pass interpretation (the “Interpretation”) and Maxwell plate modelling (the “Modelling”) of preliminary 2026 airborne versatile time-domain electromagnetic (“VTEM”) data acquired over the Alturas West Antimony Project (the “Project” or “Alturas West”) in British Columbia. Convolutions Geoscience Corp. (“Convolutions”) completed the work and provided external quality-control review of survey data during acquisition. The interpretation will be refined following review of the final processed survey data and drilling observations.

The interpretation focused on electromagnetic responses within and adjacent to the mineralized Alps-Alturas shear corridor. A series of Maxwell plate models was fitted to selected responses distributed along a structural corridor spanning more than nine hundred (900) metres, including responses beneath and adjacent to the historic Alps-Alturas mine workings. The fitted plates are simplified, non-unique representations of possible conductive sources and should not be interpreted as direct geological contacts or as evidence of a single continuous conductor.1

The Modelling provides additional constraints on the subsurface geometry of conductive features within the structural corridor and has been integrated with surface geology, historical workings, and structural measurements to refine drill targeting during the ongoing Alturas West drill program.

Highlights

More than nine hundred (900) metre modelled-response corridor: Multiple fitted Maxwell plate responses are distributed along a corridor spanning more than nine hundred (900) metres of the mapped Alps-Alturas shear zone, including responses beneath or adjacent to the historic workings (Please see Figures 1 to 3).

Modelled geometry provides structural constraints: Several fitted plates have moderate northerly dips, locally about forty-five (45) degrees, while one response is modelled with a contrasting southerly dip, indicating changes in geometry along strike (Please see Figures 2 and 3).

Possible structural complexity identified: Changes in fitted plate position and orientation along strike may be consistent with faults, structural offsets or changes in shear-zone geometry.

Drill targets refined: Integration of Maxwell plate interpretation with mapped geology, historical workings, structural measurements, and planned drill locations has helped refine the location and orientation of drill targets across Alturas West (Please see Figure 1).

Geophysical Survey & Interpretation

The 2026 VTEM survey grids across the Alturas West and East claim blocks were comprised of 354 line-kilometres (including tie lines) of helicopter-borne surveying completed by Geotech Ltd. of Aurora, Ontario, at a nominal line spacing of one hundred (100) metres.

The Interpretation focused on electromagnetic responses associated with the prospective shear zone hosting the historic Alps-Alturas antimony mine on the Alturas West claim block. Maxwell plate Modelling was used to estimate the location, orientation, and geometry of conductive sources identified within and adjacent to the structural corridor. The models were fitted line by line using simplified rectangular plate geometries. As a result, adjacent plates may overlap in the composite model; these overlaps result from the Modelling approach and should not be interpreted as evidence of overlapping or intersecting geological bodies.

In plan view, the projected footprints of multiple fitted Maxwell plates are distributed along a corridor spanning more than nine hundred (900) metres of the mapped Alps-Alturas shear corridor (Please see Figure 1). The modelled Maxwell plates provide a geophysical framework that can be compared with mapped geology, historical workings, surface mineralization, and current drilling.

Three-dimensional visualization of the line-by-line Maxwell plate models indicates that several fitted plates have moderate northerly dips, locally approximately forty-five (45) degrees and broadly consistent with the current geological interpretation. At least one fitted response toward the eastern portion of the confidently modelled corridor has a contrasting southerly dip. The change in modelled geometry may indicate local structural complexity, including changes in shear-zone orientation or structural offsets.

The Maxwell plate Interpretation has been integrated with mapped geology, historical workings, surface structural measurements, and drill targeting. Observations from the ongoing drill program will continue to be incorporated into the geological and geophysical model to evaluate the source and significance of the conductive responses.

The geological source of the conductive responses has not yet been confirmed. The geophysical data do not, on their own, establish the presence, grade or continuity of antimony mineralization. Drilling observations and physical-property measurements will be used to evaluate the source and significance of the responses.

Figure 1
Figure 1. Plan view of the Alturas West target area showing the mapped Alps-Alturas shear zone, plan-projected Maxwell plate footprints, current drill pad locations, and the >900-metre corridor spanned by the modelled responses.

Figure 2
Figure 2. Oblique three-dimensional view looking northwest showing Maxwell plate models relative to topography, the mapped Alps-Alturas shear zone, historic workings, and current drill pad locations.

Figure 3
Figure 3. Detailed oblique view near Pad 2 showing a fitted Maxwell plate model relative to the mapped Alps-Alturas shear zone and historic workings.

Ongoing Alturas West Drill Program

The Company’s ongoing drill campaign at Alturas West is focused on testing the Alps-Alturas shear zone associated with the historic Alps-Alturas antimony mine. The Maxwell plate Interpretation has been incorporated as one input to the drill-targeting process and provides additional constraints on the possible location and orientation of conductive targets along the structural corridor. The Company’s summer 2026 drill program marks the first drilling on the Project in history.

The Company expects to provide an update on the ongoing Alturas West drill program shortly, including progress to date and initial geological observations from drilling.

The Company will continue integrating drilling observations, structural measurements, and geophysical information as the program advances, with the objective of developing an increasingly detailed three-dimensional geological and structural model of the Alturas West mineralized system.

Community Engagement

Maxus recognizes that meaningful engagement with First Nations and local communities is an important component of responsible mineral exploration. The Company remains committed to maintaining transparent communication, minimizing environmental disturbance, and building respectful long-term relationships as exploration activities progress.

Marketing Extension

The Company is also pleased to announce, further to its news release on January 21, 2026, that it has increased the advertising budget and extended the term under its engagement of marketing services with RMK Marketing Inc. (“RMK”) (address: 41 Lana Terrace, Mississauga, Ont., Canada, L5A 3B2; e-mail: Roberto@rmkmarketing.ca). RMK was retained by the Company on January 21, 2026 to provide marketing services for a term of six (6) months, commencing January 23, 2026 (the “Term”), with an option to increase the advertising budget up to $500,000 CDN during the Term (the “Agreement”). Pursuant to the terms of the Agreement, the Company has decided to extend the Term from six (6) months to nine (9) months and execute its option to increase the advertising budget to $500,000 CDN by compensating RMK an additional $250,000 CDN. The Term will expire at either the end of the relevant time period or when the advertising budget is fully spent.

RMK is an independent company which will, as appropriate, co-ordinate marketing actions, maintain and optimize AdWords campaigns, adapt AdWords bidding strategies, optimize AdWords ads, provide project management and consulting for an online marketing campaign and create and optimize landing pages (the “Services”). The promotional activity will occur by Google. The Company will not issue any securities to RMK as compensation for the Services. As of the date hereof, to the Company’s knowledge, RMK (including its directors and officers) does not own any securities of the Company and has an arm’s-length relationship with the Company.

Qualified Person Statement

The scientific and technical information contained in this news release has been reviewed, verified, and approved by Morgan Verge, P.Geo., VP Exploration of the Company and a “qualified person” as defined in NI 43-101 – Standards of Disclosure for Mineral Projects. Ms. Verge has examined information regarding the historical exploration at the Project, which includes a review of the historical sampling, analytical, and procedures underlying the information and opinions contained herein. Kyle Patterson, P. Geo., President of Convolutions Geoscience Corp., has reviewed the geophysical technical disclosure contained in this news release.

Management cautions that historical results collected and reported by operators unrelated to Maxus have not been verified nor confirmed by its Qualified Person; however, the historical results create a scientific basis for ongoing work at the Project. Management further cautions that historical results, discoveries and published resource estimates on adjacent or nearby mineral properties, whether in stated current resource estimates or historical resource estimates, are not necessarily indicative of the results that may be achieved on the Project.

About Maxus Mining Inc.

Maxus Mining Inc. (CSE: MAXM | OTCQB: MXMGF | FRA: R7V) is a mineral exploration company focused on locating, acquiring, and, if warranted, advancing economic mineral properties in premier jurisdictions. The Company is actively progressing its diversified portfolio totaling approximately 16,490 hectares of prospective terrain across British Columbia, Canada.

The Portfolio includes 9,492 hectares across three antimony projects, anchored by the Flagship Alturas Antimony Project, where a recent discovery returned high-grade naturally occurring antimony up to 69.98% Sb. The Hurley Antimony Project, located adjacent to Endurance Gold Corp.’s Reliance Gold Project, where 2024 drilling reported 19.2% Sb and 2.16 g/t Au over 0.5 m‖, and the Quarry Antimony Project, which hosts historical polymetallic samples grading 0.89 g/t Au, 3.8% Cu, 0.34% Zn, 42.5% Pb, 0.65 g/t Ag, and 20% Sb‡.

Maxus’ portfolio further includes the 3,875-hectare Lotto Tungsten Project, where a selected 1980 grab sample from a scheelite-bearing quartz vein assayed 10.97% WO₃§, and the 3,123-hectare Penny Copper Project, which has over 100 years of recorded exploration. Recent work programs at Penny included rock sampling and geological mapping†, with 2017 sampling returning copper values of 1046 ppm Cu (TK17-149c), 1808 ppm Cu (TK17-28), and 2388 ppm Cu (TK17-12)†. The Project is strategically located near the historic Sullivan Mine at Kimberley, British Columbia, an area that continues to attract significant exploration activity.

Maxus Mining is committed to advancing its British Columbia projects through targeted exploration programs designed to unlock value across multiple critical mineral systems.

References

1 Alps-Alturas MINFILE – Link

 Equinox Resources – November 8, 2024, ‘Ultra High Grade Naturally Occurring Antimony at Alturas Project with Assays up to 69.98% Sb’ – Link

‖ Endurance Summarizes Antimony Results From The Reliance Gold Project, BC – Best Intervals Include 19.2% Antimony And 2.16 ppm Au Over 0.5 m In 2024 Drilling – February 24, 2025 – Link

‡ Open File 1992-11, Map Number 10.

§ MILFILE No: 082FSW228 – Loto 3, 1980 Grab Sample Link

† NI 43-101 – Technical Report on the Penny Property British Columbia, NTS 82G/12 49° 55° North Latitude -115° 90° West Longitude, Derrick Strickland P.Geo., August 14, 2024.

On Behalf of the Board of Directors

Scott Walters
Chief Executive Officer, Director
+1 (778) 374-9699
info@maxusmining.com

Disclaimer for Forward-Looking Information

This news release includes certain “Forward-Looking Statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” under applicable Canadian securities laws. When used in this news release, the words “anticipate”, “believe”, “estimate”, “expect”, “target”, “plan”, “forecast”, “may”, “would”, “could”, “schedule” and similar words or expressions, identify forward-looking statements or information.

Forward-looking statements and forward-looking information relating to any future mineral production, liquidity, enhanced value and capital markets profile of Maxus’, future growth potential for Maxus and its business, and future exploration plans are based on management’s reasonable assumptions, estimates, expectations, analyses and opinions, which are based on management’s experience and perception of trends, current conditions and expected developments, and other factors that management believes are relevant and reasonable in the circumstances, but which may prove to be incorrect. Assumptions have been made regarding, among other things, the price of copper, gold, tungsten, antimony and other metals; costs of exploration and development; the estimated costs of development of exploration projects; Maxus’ ability to operate in a safe and effective manner and its ability to obtain financing on reasonable terms.

This news release contains “forward-looking information” within the meaning of the Canadian securities laws. Statements, other than statements of historical fact, may constitute forward looking information and include, without limitation, statements with respect to the Project and its mineralization potential; the Company’s objectives, goals, or future plans with respect to the Project; further exploration work on the Project in the future; the expected benefits of completing the Interpretation and Modelling; the commencement and/or continuation of drilling or exploration programs in the future; statements with respect to the provision of the Services by RMK. With respect to the forward-looking information contained in this news release, the Company has made numerous assumptions regarding, among other things, the geological, metallurgical, engineering, financial and economic advice that the Company has received is reliable and are based upon practices and methodologies which are consistent with industry standards. While the Company considers these assumptions to be reasonable, these assumptions are inherently subject to significant uncertainties and contingencies. Additionally, there are known and unknown risk factors which could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. Known risk factors include, among others: fluctuations in commodity prices and currency exchange rates; uncertainties relating to interpretation of well results and the geology, continuity and grade of copper, gold, tungsten, antimony and other metal deposits; uncertainty of estimates of capital and operating costs, recovery rates, production estimates and estimated economic return; the need for cooperation of government agencies in the exploration and development of properties and the issuance of required permits; the need to obtain additional financing to develop properties and uncertainty as to the availability and terms of future financing; the possibility of delay in exploration or development programs or in construction projects and uncertainty of meeting anticipated program milestones; uncertainty as to timely availability of permits and other governmental approvals; increased costs and restrictions on operations due to compliance with environmental and other requirements; increased costs affecting the metals industry and increased competition in the metals industry for properties, qualified personnel, and management. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.

The Canadian Securities Exchange (CSE) does not accept responsibility for the adequacy or accuracy of this release.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/182257cb-5879-42cf-93c2-778d48cdaa3d

https://www.globenewswire.com/NewsRoom/AttachmentNg/01ca99d1-a2e4-4f99-85ee-2092631aad4e

https://www.globenewswire.com/NewsRoom/AttachmentNg/cfe6502f-7296-4a76-acbf-cba48582de25

BJJLink supports memberships, billing, payments, scheduling, attendance and student progression for UFC GYM’s new standalone Jiu Jitsu studio format

Highlights

  • The first UFC GYM Jiu-Jitsu studio is open in New York with a Florida location opening soon.
  • BJJLink is the management software platform for UFC GYM’s new jiu-jitsu studio network.
  • The platform supports memberships, billing and payment workflows, scheduling, attendance, customer management, curriculum and belt progression.
  • The openings move the partnership from rollout planning into live operations and establish additional recurring software and transaction revenue opportunities for MMA.INC.
  • The capital light model enables BJJLink to participate in studio growth without MMA.INC owning or operating the physical locations.

New York, NY, Sept. 15, 2026 (GLOBE NEWSWIRE) — Mixed Martial Arts Group Limited (NYSE American: MMA) (“MMA” or the “Company”), a technology platform for the global martial arts and combat sports industry, today announced that its BJJLink platform has been deployed at the first location opened under UFC GYM’s standalone jiu-jitsu studio rollout in New York, with a Florida academy soon to follow.

The New York studio, UFC GYM Jiu-Jitsu // Jiu Livre opened on August 8, 2026, at 383 Fifth Avenue in Manhattan. UFC GYM has described the location as its first standalone jiu-jitsu studio. A second location is expected to open in January 2027 in Florida.

Under MMA.INC’s existing multi-year agreement with UFC GYM, BJJLink provides the operating technology for the new studio format. Its platform brings membership administration, recurring billing, payment orchestration, class scheduling, attendance, customer engagement, curriculum management and belt progression into a single system.

Through MMA.INC’s payments ecosystem, BJJLink serves as the system of record for, and administers, all underlying member transactions, integrating with payment providers selected for each region to optimize adoption, reliability and commercial outcomes.

“The important point for shareholders is that this partnership is now operating in live studio,” said Nick Langton, Founder and Chief Executive Officer of MMA.INC. “BJJLink is providing the day-to-day technology supporting memberships, billing, payments, scheduling, attendance and student progression.”

“This first opening demonstrates how our existing platform can be deployed through established gym and franchise networks. Each additional location has the potential to add recurring software revenue and transaction activity without requiring MMA.INC to own or operate physical gyms.”

A Scalable Market Opportunity

Brazilian jiu-jitsu forms part of a large and fragmented global martial arts economy comprising independent academies, multi-location operators and branded gym networks.

IBISWorld estimated that the United States martial arts studio industry alone comprised approximately 46,600 businesses and generated approximately US$19.4 billion in annual revenue. Its scale and fragmentation create a substantial addressable market for purpose-built academy software, payment infrastructure and operating tools that help academies manage members, transactions and day-to-day operations.

The deployment of BJJLink across the first UFC GYM Jiu-Jitsu studios provides further operating validation for the platform and its ability to support standardized systems across multi-location networks.

Industry data source: IBISWorld, Martial Arts Studios in the US, December 2024.

About Mixed Martial Arts Group Limited

Mixed Martial Arts Group Limited (NYSE American: MMA), doing business as MMA.INC, is building the participation and technology platform for the global martial arts and combat sports industry, connecting practitioners, gyms, coaches, content, commerce and payments.

As of July 2026, MMA.INC’s platform assets included 5 million+ social media followers, 680,000 user profiles, 107,694 registered student profiles, 27,651 monthly active users and 15,326 published gym profiles, including 996 verified and 389 paying academies. The platform also recorded approximately 80,000 monthly check-ins and an annualized payments run rate of approximately US$21 million based on May 2026 processing volumes.

  • A Connected Participation Platform: MMA.INC brings together gym software, payments, training, community, content and commerce through assets including BJJLink, TrainAlta, Hype and MixedMartialArts.com.
  • A Growing Participation Network: Over the prior 18 months, registered student profiles increased approximately 101%, monthly active users approximately 89% and paying academies approximately 260%.
  • Built to Aggregate the Sector: MMA.INC’s strategy is to connect the fragmented martial arts participation economy through a unified digital identity and ecosystem designed to deepen engagement and expand monetization across software, payments, programs, memberships, partnerships and commerce.

For more information, visit www.mma.inc

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Sections 27A of the Securities Act of 1933 and 21E of the Securities Exchange Act of 1934. Words such as “believe,” “may,” “estimate,” “anticipate,” “intend,” “plan,” “could,” “target,” “potential,” “will,” “expect” and similar expressions are intended to identify forward-looking statements. These statements include, without limitation, statements regarding MMA.INC’s strategy, plans and objectives; growth and monetization of its platform; conversion of fans into participants; increased penetration of existing users, students, gyms and other platform assets; development, rollout and adoption of products and programs, including XP Passport and the Warrior Training Program; partnerships, geographic expansion, acquisitions, strategic investments and other inorganic growth opportunities; payment volumes; and future revenue, margins, operating performance and financial condition. Forward-looking statements are based on management’s current expectations, assumptions and estimates and are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. These include, among others, the Company’s ability to manage growth; the adoption and commercialization of its products and services; its dependence on gyms, academies, members, partners and key relationships; competition; execution and integration risks associated with acquisitions; regulatory developments; macroeconomic conditions; access to capital; and the risks described in the Company’s Annual Report on Form 20-F and subsequent reports on Form 6-K filed with or furnished to the U.S. Securities and Exchange Commission. There can be no assurance that any forward-looking outcome will be achieved. MMA.INC’s products and business lines are at varying stages of development, commercialization and adoption, and certain products, services or features may be modified, delayed or discontinued. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update or revise any forward-looking statement except as required by applicable law.

Media Contacts

Mixed Martial Arts Group Limited
E: andrew@mma.inc

VANCOUVER, British Columbia, Sept. 15, 2026 (GLOBE NEWSWIRE) — Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (OTCQB: PPURF) (“Purecore” or the “Company”) is pleased to announce that it has commenced a comprehensive data compilation and technical review program at the Yurchison Uranium Property (“Yurchison” or the “Property”) in the Athabasca Basin, northern Saskatchewan.

Purecore holds an option to earn up to a 100% interest in Yurchison pursuant to its definitive option agreement with Skyharbour Resources Ltd. (TSXV: SYH). The Property comprises 22 claims covering approximately 35,029 hectares and is located approximately 75 kilometres south of Cameco Corporation’s Rabbit Lake operation.

The program is intended to consolidate historical and modern geological, geochemical, geophysical and exploration information into an integrated project database and geological framework. The resulting dataset will be used to refine areas of interest, identify where multiple layers of technical evidence converge and prioritize targets for potential future field exploration.

Peter Berdusco, President and Chief Executive Officer of Purecore, commented:

“Yurchison has decades of exploration history and a significant volume of modern geophysical data. This program brings that information together into an integrated geological framework to refine our understanding of the Property and prioritize areas for future exploration.”

Data Compilation and Target Generation

Yurchison has been subject to historical airborne and ground geophysical surveys, geological mapping, prospecting, geochemical sampling and historical drilling. Much of the earlier exploration was completed prior to 2000, with additional modern airborne geophysical work completed in recent years.

The current program is expected to include:

  • compilation and digitization of available historical geological, geochemical, geophysical and drilling information;
  • integration and interpretation of historical and modern airborne geophysical datasets;
  • review of historical uranium occurrences, prospecting results and previous exploration targets;
  • assessment of structural and geological controls that may be relevant to uranium mineralization;
  • comparison of geophysical conductors, structural features, geochemical anomalies and historical exploration results; and
  • ranking of priority areas for potential follow-up exploration.

Previous work at Yurchison includes a 1,424 line-kilometre high-resolution airborne magnetic survey completed at 50-metre line spacing, as well as earlier VTEM work that identified multiple geophysical zones of interest. Additional airborne magnetic, radiometric and VLF-EM surveys have also been completed across the Property.

Historical exploration at Yurchison identified uranium mineralization in several areas of the Property, including prospecting near historical trenches that returned values ranging from 0.09% to 0.30% U₃O₈. These results, together with historical and modern geophysical datasets, will form part of the current compilation and technical review.

Yurchison Uranium Property

Yurchison comprises approximately 35,029 hectares in the Wollaston Domain of northern Saskatchewan. The Property is underlain by Wollaston Supergroup metasedimentary gneisses, including graphitic units adjacent to Archean granitic gneisses, and has seen historical exploration for uranium. Highway 905 provides access through the Property area.

The majority of historical exploration was completed prior to 2000, and significant portions of the Property have received limited modern follow-up. Purecore intends to use the current compilation and interpretation program to establish a stronger technical foundation for future exploration planning.

Qualified Person

The technical information in this news release has been reviewed and approved by Dr. Dennis LaPoint, P.Geo., an independent Qualified Person within the meaning of National Instrument 43-101 – Standards of Disclosure for Mineral Projects.

About Purecore Metals Inc.

Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (OTCQB: PPURF) is a Canadian critical minerals company building a uranium and copper portfolio positioned around the long-term expansion of global electricity demand.

The Company holds an option to earn up to a 100% interest in the Yurchison Uranium Property in northern Saskatchewan and owns a 100% interest in the Bankier Property, a critical minerals project in British Columbia.

For more information, visit Purecore’s website www.purecoremetals.com.

Investor Contact
investors@purecoremetals.com
1.877.844.4661

On behalf of the Board of Directors

Peter Berdusco
President and Chief Executive Officer
Purecore Metals Inc.

Forward-Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian securities laws, including statements regarding the Company’s data compilation, technical review, target-generation and exploration activities at the Yurchison Uranium Property; the integration and interpretation of historical and modern exploration data; the identification and prioritization of exploration targets; future fieldwork and exploration programs; the potential acquisition by Purecore of up to a 100% interest in Yurchison; and the Company’s broader exploration and growth strategy.

Forward-looking information is based on assumptions management considers reasonable as of the date of this news release and is subject to known and unknown risks and uncertainties that could cause actual results to differ materially. Such risks include, among others, exploration and geological risk; the completeness, accuracy and usefulness of historical exploration information; the possibility that compilation and interpretation work will not identify targets warranting further exploration; the availability of capital; commodity-price and market conditions; regulatory and permitting requirements; the Company’s ability to satisfy the terms and conditions of the Yurchison option agreement; and other risks associated with mineral exploration and development.

There can be no assurance that the current program will result in the identification of an economic mineral deposit or that any targets identified will be advanced to drilling or other future exploration. Readers are cautioned not to place undue reliance on forward-looking information. The Company will update or revise forward-looking information only as required by applicable securities laws.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Pulsed Magnetic-Field Experiments Produce Hotter, Denser Toroidal Plasmas While Demonstrating Plasma Stability

FORT WORTH, Texas, Sept. 15, 2026 (GLOBE NEWSWIRE) — American Fusion Inc. (AMFN) (“American Fusion” or the “Company”), a developer of advanced fusion-energy technology, today announced results from the latest series of experiments conducted by the American Fusion™ technical team at the Company’s facility involving its proprietary Texatron™ fusion-energy technology.

The latest experiments represent an important advancement in the Company’s ongoing development program. The AMFN team used high-voltage capacitor banks to generate a series of short-duration, high-intensity pulsed magnetic fields designed to rapidly compress—or implode—a toroidal plasma.

According to observations from the experimental program, the pulsed magnetic-field configuration produced toroidal plasmas that were hotter and denser than those generated during the Company’s earlier high-current experiments. Importantly, the Company also reports that the resulting toroidal plasma structures remained stable against significant magnetohydrodynamic (“MHD”) instabilities during the experimental pulse.

Supporting the Texatron™ Shock-Heating Concept

The Texatron™ is being developed around a pulsed approach to fusion rather than attempting to maintain plasma continuously for extended periods.

In the latest configuration, electrical energy stored in a capacitor bank is released rapidly to create an intense transient magnetic field. The field compresses the electrically conducting toroidal plasma. Rapid compression can increase plasma density while shock processes can convert part of the compression energy into thermal energy, increasing plasma temperature.

American Fusion believes the latest observations support two important elements of the Texatron™ development concept: rapid magnetic compression can produce increasingly hot and dense toroidal plasmas, and the toroidal structure can remain organized during the violent compression event rather than immediately being disrupted by MHD instabilities.

Plasma stability is particularly important because fusion performance ultimately depends not simply upon achieving high temperature, but upon simultaneously achieving sufficient temperature, fuel density and confinement.

“These latest experiments were extraordinary to witness,” said Dr. John E. Brandenburg, Chief Technology Officer of American Fusion. “From a scientific-development standpoint, it feels like playing 18 holes of golf and getting a hole-in-one on every hole. Test after test, we saw the behavior we were looking for: strong magnetic compression, hotter and denser plasma, and a remarkably robust toroidal plasma structure. These results give our team increased confidence in the fundamental Texatron™ concept and a very clear direction for the next phase of testing.”

Independent Observation of the Test Program

The Company said the experimental sessions were also observed by Fabrice David, who was present throughout the latest testing program.

“I was personally present for every test session in this series and observed the experiments and the resulting data,” said Fabrice David. “Based on what I personally witnessed and reviewed during the testing, I can independently confirm the results reported from these test sessions. The consistency of the observed plasma behavior across the experiments was particularly noteworthy.”

The Company notes that Mr. David’s statement represents his independent observation and review of the testing and should not be interpreted as third-party laboratory certification, peer review or independent validation of commercial fusion performance unless and until such testing is conducted under an applicable independent verification protocol.

From Plasma Compression to Direct Electricity

The experiments are also relevant to another important element of the Texatron™ architecture: American Fusion’s proposed direct magnetic-to-electric energy-conversion system.

The Company is developing Texatron™ around the use of deuterium and helium-3 (D–³He) as fusion fuels. The principal D–³He reaction releases most of its fusion energy in energetic charged particles.

American Fusion’s concept is that, following each fusion pulse, energy deposited into the toroidal plasma causes the plasma to expand against the surrounding magnetic field. The changing magnetic flux created by that expansion can then induce electrical current in surrounding conductors.

In this architecture, the energized toroidal plasma would effectively function as a magnetic armature within an electrical generator. The conceptual sequence is:

electrical pulse → magnetic compression → shock heating → fusion → plasma expansion → changing magnetic field → electrical output.

The Company’s development objective is ultimately to convert fusion energy into electricity electromagnetically, potentially reducing reliance on the conventional heat → steam → turbine → generator cycle used by most thermal power plants. The direct-conversion concept remains under development and has not yet been demonstrated as a commercial power-generation system.

Why Plasma Stability Matters

A plasma is an extremely hot collection of electrically charged particles. Unlike an ordinary gas, plasma responds strongly to electric and magnetic fields.

One of the longstanding challenges in fusion research is that a hot plasma can develop instabilities that cause it to distort, move, or lose confinement. These behaviors are commonly described through magnetohydrodynamics, or MHD.

The Texatron™ approach seeks to create a stable, toroidal—or doughnut-shaped—plasma and then compress that structure extremely rapidly with pulsed magnetic fields.

A simple analogy is a magnetic smoke ring. If the ring maintains its structure while being rapidly squeezed from the outside, its density and temperature can increase dramatically. The latest experiments showed that the Texatron™ toroidal plasma remained organized during this compression process.

Next Phase of Texatron™ Testing

American Fusion said its technical team will continue increasing the sophistication of its experimental program, with emphasis on quantitative measurement and repeatability.

Future testing is expected to focus on characterizing plasma temperature, density, magnetic-field strength, compression behavior, confinement time and stability, while continuing development toward D–³He fusion-relevant operating conditions.

The Company also intends to continue evaluating the magnetic-armature concept and the ability of the Texatron™ architecture to recover energy electromagnetically from an expanding plasma.

“These experiments are important because we are not simply trying to make a plasma,” said Brent Nelson, Executive Chairman of American Fusion Inc. “We are systematically testing the individual physical principles that have to work together for Texatron™ to accomplish its ultimate objective. Seeing hotter, denser and stable toroidal plasmas from the new pulsed magnetic-field configuration is an encouraging development for the entire American Fusion™ team.”

Leadership and Engineering Update

As American Fusion™ accelerates the Texatron™ development and testing program, Travis Yakimishyn is assuming the new role of Senior Electrical Engineer, allowing him to take an even more hands-on role in the Company’s engineering activities. In this position, Yakimishyn will focus his experience directly on the design, development, testing and advancement of electrical and technical solutions supporting the Texatron™ platform. The Company believes this increased engineering focus will further strengthen the technical team as American Fusion™ progresses from its current experimental program toward increasingly advanced Texatron™ systems.

About American Fusion Inc.

American Fusion Inc. (OTCQB: AMFN) is an advanced energy platform company focused on the development and commercialization of next-generation fusion energy technologies. The Company is advancing the Texatron™ Fusion Engine™ aneutronic fusion platform, designed for modular, infrastructure-grade deployment across industrial, commercial, defense and grid-constrained applications.

The Company’s development strategy emphasizes system-level engineering, disciplined intellectual-property protection and scalable architectures intended to support long-term commercial operation, while maintaining a focus on capital discipline and transparent corporate governance.

For more information about American Fusion and its Texatron™ platform, please visit: americanfusionenergy.com

For an overview of American Fusion, please click here: American Fusion Overview

Forward-Looking Statements

This press release contains forward-looking statements regarding future events and the future performance of American Fusion Inc., including statements regarding American Fusion’s intellectual property portfolio and pending and future patent applications; the development, testing, validation, anticipated performance, scalability and potential applications of the Texatron™ Fusion Engine™; commercialization, manufacturing, financing, strategic partnerships, regulatory approvals and customer opportunities; the Company’s evaluation of a potential listing on the Texas Stock Exchange; satisfaction of applicable listing standards and completion of any related corporate or capital-markets actions; and other future business operations. Words such as “anticipate,” “believe,” “could,” “expect,” “intend,” “may,” “plan,” “potential,” “should,” “will” and similar expressions are intended to identify forward-looking statements.

Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Patent applications are subject to examination and there can be no assurance that any application will result in an issued or commercially valuable patent. The developed Texatron™ Fusion Engine™ is undergoing testing and continued engineering validation and has not demonstrated sustained net electricity generation from a commercial system. There can be no assurance that the Company will achieve its scientific, engineering, regulatory, financing, manufacturing or commercialization objectives, satisfy the applicable initial listing standards of TXSE, receive approval to list its common stock on TXSE or complete any potential listing. This press release does not constitute an offer to sell or solicitation of an offer to purchase securities. Readers should not place undue reliance on forward-looking statements, and American Fusion undertakes no obligation to update them except as required by law.

Corporate Communications

833-872-2636 ext. 730
ir@americanfusionenergy.com
info@americanfusionenergy.com
americanfusionenergy.com

NDA supported by positive results from the APEX pivotal trial demonstrating clinically meaningful responses and evidence of disease modification in patients with AdvSM

PDUFA target action date set for June 29, 2027

WALTHAM, Mass. and BOULDER, Colo., Sept. 15, 2026 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for bezuclastinib in patients with Advanced Systemic Mastocytosis (AdvSM) and assigned a Prescription Drug User Fee Act (PDUFA) target action date of June 29, 2027. In addition, the FDA communicated that at this time, there is no plan to hold an advisory committee, nor have they identified any potential review issues.

“With the FDA’s acceptance of our NDA in Advanced Systemic Mastocytosis, we have reached another important regulatory milestone for bezuclastinib and are one step closer to potentially bringing this therapy to patients with AdvSM,” said Andrew Robbins, Cogent’s President and Chief Executive Officer. “Together with the NDAs currently under review for NonAdvSM and GIST patients, this milestone further reinforces the potential of bezuclastinib across multiple patient populations with KIT-driven diseases. With an excellent commercial and medical team in place, we are excited and ready for the potential launches later this year.”

The NDA acceptance is supported by data from the APEX pivotal trial, which was most recently presented at the 2026 European Hematology Association (EHA) Congress, in which bezuclastinib demonstrated clinically meaningful responses and durable clinical activity in patients with AdvSM. As of the March 31, 2026 data cutoff, the primary endpoint of response per mIWG-MRT-ECNM criteria demonstrated a 65% overall response rate, including 57% of patients achieving CR, CRh or PR as best response. Response by pure pathological response (PPR) criteria was 81%. Bezuclastinib also demonstrated durable clinical activity, with a 12-month progression-free survival rate of 79% and 12-month overall survival rate of 87%, with median PFS and OS not yet mature.

Cogent continues to advance bezuclastinib toward potential approvals and commercialization across its three indications. The Company’s NDA for NonAdvanced Systemic Mastocytosis is under FDA review, with a PDUFA target action date of December 30, 2026, and the NDA for GIST is also under FDA review, with a PDUFA target action date of November 30, 2026. Together, these regulatory milestones represent significant progress toward bringing bezuclastinib to patients across a broad spectrum of KIT-driven diseases.

Bezuclastinib – Expanded Access Program
Working with the FDA, Cogent has established active Expanded Access Programs (EAPs) for U.S. patients with SM or GIST who meet disease-specific criteria and could benefit from treatment with bezuclastinib or the combination of bezuclastinib and sunitinib. For more information please visit: https://www.cogentbio.com/bezuclastinib-program-development/#our-expanded-access-policy.

Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cogent also announced today that, on September 10, 2026, the Compensation Committee of Cogent’s Board of Directors, made up entirely of independent directors, approved the grants of “inducement” equity awards to nine new employees under the company’s 2020 Inducement Plan with grant dates of September 10, 2026 and September 14, 2026. The awards were approved in accordance with Listing Rule 5635(c)(4) of the corporate governance rules of the Nasdaq Stock Market. The employees received, in the aggregate, (i) nonqualified options to purchase 39,300 shares of Cogent common stock and (ii) 33,600 restricted stock units (RSUs). Each option has a 10-year term, an exercise price equal to the closing price of Cogent’s common stock on the grant date, and a 4-year vesting schedule with 25% vesting on the 1-year anniversary of the grant date and the remainder vesting in equal monthly installments over the subsequent 36 months, provided such employee remains employed through each such vesting date. The RSUs vest annually in equal installments over 4 years from the grant date, provided such employee remains employed through each such vesting date.

About Cogent Biosciences, Inc.
Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving systemic mastocytosis, a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. In addition, the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα, KRAS and JAK2. Cogent Biosciences is based in Waltham, MA and Boulder, CO. Visit our website for more information at www.cogentbio.com. Follow Cogent Biosciences on social media: X  and LinkedIn. Information that may be important to investors will be routinely posted on our website and X.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding: the potential for regulatory approval and commercialization of bezuclastinib across three indications: patients with GIST, NonAdvSM and AdvSM; bezuclastinib’s potential across multiple KIT-driven diseases and the potential commercial launches of bezuclastinib later this year. The use of words such as, but not limited to, “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” and similar words expressions are intended to identify forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, our clinical results, the rate of enrollment in our clinical trials and other future conditions. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. We may not actually achieve the forecasts or milestones disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Such forward-looking statements are subject to a number of material risks and uncertainties including but not limited to those set forth under the caption “Risk Factors” in Cogent’s most recent Quarterly Report on Form 10-Q filed with the SEC. Any forward-looking statement speaks only as of the date on which it was made. Neither we, nor our affiliates, advisors or representatives, undertake any obligation to publicly update or revise any forward-looking statement, whether as result of new information, future events or otherwise, except as required by law. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date hereof.

CONTACT: Contact:

Christi Waarich
Senior Director, Investor Relations
christi.waarich@cogentbio.com
617-830-1653

TULSA, Okla., Sept. 15, 2026 (GLOBE NEWSWIRE) — ONEOK, Inc. (NYSE: OKE) today announced the results to date of ONEOK, L.L.C.’s (“OpCo”) previously announced cash tender offers (the “Tender Offers”) to purchase up to an aggregate principal amount that will not result in an aggregate purchase price that exceeds $2 billion (subject to increase or decrease by OpCo, the “Aggregate Maximum Tender Amount”) of OpCo’s debt securities listed in the table below (the “Notes” and, each series, a “series of Notes”), subject to the order of priority as set forth in the table below under “Acceptance Priority Level,” upon the terms and subject to the conditions set forth in the Offer to Purchase, dated August 30, 2026 (the “Offer to Purchase”), in order to accept all of the Notes that were validly tendered and not validly withdrawn at or prior to the Early Tender Deadline (as defined below). As a result of the reorganization transactions described in the Offer to Purchase, the Notes are fully and unconditionally guaranteed by ONEOK, as Parent Guarantor.

According to information received from D.F. King & Co., Inc., the Information and Tender Agent for the Tender Offers, as of 5:00 p.m., New York City time, on September 14, 2026 (the “Early Tender Deadline”), OpCo had received valid tenders from the registered holders (the “Holders”) of the Notes that were not validly withdrawn as set forth in the table below.

Acceptance
Priority Level
(1)
Title of
Notes
Principal
Amount
Outstanding
(in millions)
CUSIP
Number
Reference
U.S. Treasury
Security
Fixed Spread
(Basis
Points)
Aggregate
Principal Amount
Tendered at Early
Tender Deadline
1 3.950% Senior Notes due 2050 $797 682680CA9 5.000% UST due May 15, 2056 + 100 $368,067,000
2 4.200% Senior Notes due 2047 $500 682680BY8 5.125% UST due August 15, 2046 + 95 $197,563,000
3 4.500% Senior Notes due 2050 $271 682680BC6 5.000% UST due May 15, 2056 + 105 $100,821,000
4 4.200% Senior Notes due 2045 $250 682680BW2 5.125% UST due August 15, 2046 + 100 $63,789,000
5 4.250% Senior Notes due 2046 $500 682680BX0 5.125% UST due August 15, 2046 + 95 $203,342,000
6 4.450% Senior Notes due 2049 $380 682680AZ6 5.125% UST due August 15, 2046 + 100 $85,954,000
7 4.200% Senior Notes due 2042 $250 682680BU6 5.125% UST due August 15, 2046 + 95 $25,679,000
8 4.850% Senior Notes due 2049 $500 682680BZ5 5.125% UST due August 15, 2046 + 100 $195,395,000
9 4.950% Senior Notes due 2047 $407 682680AT0 5.125% UST due August 15, 2046 + 100 $158,978,000
10 5.050% Senior Notes due 2045 $413 682680CY7 5.125% UST due August 15, 2046 + 95 $166,881,000
11 5.200% Senior Notes due 2048 $753 682680AV5 5.125% UST due August 15, 2046 + 95 $369,646,000
12 5.150% Senior Notes due 2043 $550 682680BV4 5.125% UST due August 15, 2046 + 90 $149,698,000
13 5.450% Senior Notes due 2047 $448 682680DA8 5.125% UST due August 15, 2046 + 100 $296,908,000
14 5.700% Senior Notes due 2054 $1,480 682680CF8 5.000% UST due May 15, 2056 + 110 $862,308,000
15 5.850% Senior Notes due 2064 $722 682680CG6 5.000% UST due May 15, 2056 + 120 $345,431,000
16 5.600% Senior Notes due 2044 $340 682680CW1 5.125% UST due August 15, 2046 + 100 $165,176,000
17 3.100% Senior Notes due 2030 $780 682680BB8 4.375% UST due August 31, 2031 + 35 $472,793,000
18 3.250% Senior Notes due 2030 $500 682680BS1 4.375% UST due August 31, 2031 + 35 $210,140,000
19 3.400% Senior Notes due 2029 $714 682680AY9 4.250% UST due August 15, 2029 + 30 $421,157,000
20 5.050% Senior Notes due 2034 $1,600 682680CE1 4.625% UST due August 15, 2036 + 75 $1,042,539,000

(1) Subject to the satisfaction or waiver of the conditions of the Tender Offers described in the Offer to Purchase, including the Aggregate Maximum Tender Amount and proration, the principal amount of each series of Notes accepted for purchase will be determined in accordance with the applicable Acceptance Priority Level specified in the table above (with 1 being the highest Acceptance Priority Level and 20 being the lowest Acceptance Priority Level). Notes tendered at or prior to the Early Tender Deadline will be accepted for purchase in priority to Notes tendered after the Early Tender Deadline, regardless of the Acceptance Priority Level of such later-tendered Notes, as described in the Offer to Purchase under “Description of the Offers—Aggregate Maximum Tender Amount; Acceptance Priority Levels; Proration.”

The determination of the Early Tender Consideration (as defined in the Offer to Purchase) will occur at 9:00 a.m., New York City time, on September 15, 2026. The settlement date for the Notes that are validly tendered at or prior to the Early Tender Deadline is expected to be September 17, 2026.

Although the Tender Offers are scheduled to expire at 5:00 p.m., New York City time, on September 29, 2026, because the aggregate principal amount of all Notes validly tendered and not validly withdrawn by the Early Tender Deadline is equal to the Aggregate Maximum Tender Amount, OpCo does not expect to accept for purchase any tenders of Notes after the Early Tender Deadline. Any Notes tendered after the Early Tender Deadline will be promptly credited to the account of the Holders of such Notes maintained at the Depository Trust Company and otherwise returned in accordance with the Offer to Purchase.

Full details of the terms and conditions of the Tender Offers are described in the Offer to Purchase, which was sent by OpCo to Holders of the Notes. Holders of the Notes are encouraged to read the Offer to Purchase as it contains important information regarding the Tender Offers.

OpCo has retained Barclays Capital Inc. to serve as Dealer Manager for the Tender Offers. D.F. King & Co., Inc. has been retained to serve as the Information and Tender Agent for the Tender Offers. Questions regarding the Tender Offers may be directed to Barclays Capital Inc. at 745 Seventh Avenue, 5th Floor, New York, New York 10019, (800) 438-3242 (toll free) or (212) 528-7581 (collect). Requests for the Offer to Purchase may be directed to D.F. King & Co., Inc. at 28 Liberty Street, 53rd Floor, New York, New York 10005, (646) 690-9645 (for banks and brokers) or (800) 967-7510 (for all others), or by email (OKE@dfking.com). OpCo is making the Tender Offers only by, and pursuant to, the terms of the Offer to Purchase. None of OpCo, the Dealer Manager, or the Information and Tender Agent make any recommendation as to whether Holders should tender or refrain from tendering their Notes. Holders must consult their own investment and tax advisors and make their own decisions as to whether to tender their Notes and, if so, the principal amount of the Notes to tender. The Tender Offers are not being made to holders of the Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. In any jurisdiction in which the securities laws or blue sky laws require the Tender Offers to be made by a licensed broker or dealer, the Tender Offers will be deemed to be made on behalf of OpCo by the Dealer Manager, or one or more registered brokers or dealers that are licensed under the laws of such jurisdiction.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy the securities described above, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

——————————————————————————————————————        
At ONEOK (NYSE: OKE), we deliver energy products and services vital to an advancing world. We operate as a holding company, and our operations are conducted through OpCo and its subsidiaries. We are a leading midstream operator that provides gathering, processing, fractionation, transportation, storage and marine export services. Through our approximately 60,000-mile pipeline network, we transport the natural gas, natural gas liquids (NGLs), refined products and crude oil that help meet domestic and international energy demand, contribute to energy security and provide safe, reliable and responsible energy solutions needed today and into the future. As one of the largest integrated energy infrastructure companies in North America, ONEOK is delivering energy that makes a difference in the lives of people in the U.S. and around the world.

ONEOK is an S&P 500 company headquartered in Tulsa, Oklahoma.

This communication contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, included in this communication that address activities, events or developments that ONEOK expects, believes or anticipates will or may occur in the future are forward-looking statements.

These forward-looking statements include, but are not limited to, statements regarding timing and consummation of the purchase of the Notes, risks and uncertainties related to the satisfaction of the conditions related to the purchase of the Notes. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included in this communication. These include the risk that changes in ONEOK’s capital structure could have adverse effects on the market value of its securities; the risk that ONEOK may be unable to reduce expenses or access financing or liquidity; risks related to the impact of any economic downturn and any substantial decline in commodity prices; risks related to ONEOK’s ability to effectively manage our expanded operations following closing of recent acquisitions and other important factors that could cause actual results to differ materially from those projected.

Forward-looking statements include the items identified in the preceding paragraph, the information concerning possible or assumed future results of our operations and other statements contained or incorporated in this news release identified by words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “goal,” “guidance,” “intend,” “may,” “might,” “outlook,” “plan,” “potential,” “project,” “scheduled,” “should,” “will,” “would” and other words and terms of similar meaning.

One should not place undue reliance on forward-looking statements. Known and unknown risks, uncertainties and other factors may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by forward-looking statements. Those factors may affect our operations, markets, products, services and prices. These and other risks are described in greater detail in Item 1A, Risk Factors, in our most recent Annual Report on Form 10-K and in the other filings that we make with the Securities and Exchange Commission (SEC), which are available on the SEC’s website at www.sec.gov. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these factors. Any such forward-looking statement speaks only as of the date on which such statement is made, and, other than as required under securities laws, we undertake no obligation to update publicly any forward-looking statement whether as a result of new information, subsequent events or change in circumstances, expectations or otherwise.

Contacts:

Investor Relations:
Megan Patterson
918-561-5325
ONEOKInvestorRelations@oneok.com

Media Relations:
Alicia Keenom
918-861-3749
Media@oneok.com

The HP ZBook Ultra G3a 16, the most capable local agentic laptopi, powered by AMD and enhanced by Perplexity, makes AI work where work happens

A Personal AI Factory for Professionals

The HP ZBook Ultra G3a 16” combines workstation-class performance, local AI capabilities, and intelligent workflow experiences for demanding professional environments. Powered by AMD and enhanced by Perplexity, it is designed to help professionals apply agentic AI to defined tasks and support large local AI models, AI agents, and professional applications in a thin-and-light mobile form factor.
The HP ZBook Ultra G3a 16” combines workstation-class performance, local AI capabilities, and intelligent workflow experiences for demanding professional environments. Powered by AMD and enhanced by Perplexity, it is designed to help professionals apply agentic AI to defined tasks and support large local AI models, AI agents, and professional applications in a thin-and-light mobile form factor.

News Highlights:

  • The new HP ZBook Ultra G3a, a thin-and-light 16-inch mobile workstation, supports advanced workloads, including up to 300B-parameter LLMs locally, with up to 192GB unified memory and 160GB dedicated to the VRAM, enabling users to simultaneously run multi-agent and professional AI workflows.
  • Perplexity Computer comes preloaded, including supported integration for Autodesk Revit, helping professionals apply AI to defined tasks without starting from an empty prompt box.

PALO ALTO, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) — HP Inc. today announced the HP ZBook Ultra G3a, a new mobile workstation designed from the ground up to serve as a personal AI factory for professionals. Powered by AMD and enhanced by Perplexity, the HP ZBook Ultra G3a 16” combines workstation-class performance, local AI capabilities, and intelligent workflow experiences for demanding professional environments.

As organizations move from AI experimentation to production, professionals still face fragmented tools, disconnected applications, and complex setup requirements. HP is addressing that gap by bringing together AMD-powered local performance, Perplexity Computer to complete end-to-end work, and Autodesk®ii application support in one mobile workstation built for professional use.

“Professionals need AI experiences that are powerful, reliable, and integrated into the way they work,” said Jim Nottingham, Senior Vice President and Division President, Advanced Compute and Solutions, HP Inc. “With the HP ZBook Ultra G3a 16”, HP is bringing a local AI factory and workflow-ready tools together to help customers apply agentic AI to their most demanding work.”

Local AI performance, engineered with AMD

HP and AMD co-engineered the HP ZBook Ultra G3a 16” to support large local AI models, AI agents, and professional applications in a thin-and-light mobile form factor. Powered by up to AMD Ryzen AI Max+ PRO 495 and up to 192 GB of unified memory, this single-chip system helps professionals design, build, analyze, and run AI locally without moving work to a larger system or relying on the cloud for every task.

“Together, HP and AMD are ushering in the era of Personal AI, where extraordinary AI power moves from the data center into the hands of professionals. For years, the most powerful AI has lived in the cloud,” said Jack Huynh, Senior Vice President and General Manager of the Computing and Graphics Group at AMD. “Now, with up to 192GB of unified memory and the ability to run models up to 300 billion parameters locally, that power is right beside you, working alongside you and your most demanding applications. The new ZBook shows what’s possible when AI becomes truly personal, giving people the freedom to explore bigger ideas, solve harder problems, and bring their most ambitious ideas to life.”

This on-device approach can help organizations reduce cloud dependency and manage inference costs, while giving professionals more control over performance, latency, privacy, and where work runs.

Agentic AI, ready for professional workflows

The HP ZBook Ultra is engineered to run large local models, AI agents, and demanding professional applications at the same time. Ready-to-use workflow tools help customers apply AI to defined tasks without requiring teams to assemble hardware, models, connectors, prompts, and instructions on their own.

“Professionals shouldn’t have to build their own AI stack to put their workstation to work,” said Ryan Foutty, Vice President of Business at Perplexity. “With HP, we’re bringing them Portable Computer, a mode of Personal Computer that runs AI models, agents, and tools on the device. Work starts locally, and when a step needs frontier intelligence, users can choose to bring in a cloud model without starting over. Businesses get the benefits of local AI without giving up access to the cloud or control over when they use it.”

HP and Perplexity are enabling professionals to use AI more effectively with the applications they already rely on. Powered by Perplexity Portable Computer for Windows’s MCP Connector to Autodesk Revit®, customers can use local, on-device AI alongside their project data, keeping proprietary data on-device and minimizing cloud token costs. This helps professionals spend less time selecting tools, finding instructions, and writing prompts, and more time designing, creating, and solving problems. Additionally, Perplexity and HP have co-developed task-based Skills exclusively available to HP customers, designed to help users offload repetitive tasks and spend more time doing the work they enjoy.

Mobile workstation performance for advanced workloads

Built for all-day productivity on the go, the HP ZBook Ultra G3a 16″ gives architects, engineers, designers, and technical teams workstation-class performance in a highly mobile design starting at 4.2 lbs. and 17.9 mm thin. A new thermal design delivers up to 81.8% higher TDPiii, enabling up to 100W of performance for advanced workloads away from the desk.

  • Run complex AI models, agents, and advanced workloads simultaneously, including up to 300B-parameter LLMs locally, powered by AMD Radeon™ integrated graphics with up to 192GB unified memory, 160GB dedicated VRAM, and 55 TOPS NPU.
  • Support demanding design and visualization workflows, including Autodesk Revit 2027, Autodesk 3ds Max, and Chaos Enscape visualization.
  • Stay productive beyond Wi-Fi with secure 5G through HP Go connectivity.
  • Extend device life and simplify serviceability with an easily IT-replaceable keyboard and design features built for long-term use.

A more controlled path for IT

IT leaders are being asked to support AI adoption while managing cost, security, and governance. The HP ZBook Ultra G3a 16” is a new anchor in HP’s broader agentic AI portfolio, alongside HP ZGX Nano, HP ZGX Fury, HP Boost, and HP Remote System Controller, giving IT teams a more controlled path to scale local AI.

In addition, HP’s new Local AI Value Calculator, available on HP.com will bring HP Z workstations customers a clear understanding of how moving AI workloads from the cloud to local devices can lower costs, provide valuable insight into performance, and help deliver faster return on investment for everyday AI use.

By supporting local inference, large memory capacity, elastic scaling, and longer device life, HP gives organizations greater flexibility as AI models, frameworks, and workflows evolve.

Pricing and availability

The HP ZBook Ultra G3a 16” is expected to be available in October 2026. Pricing will be provided closer to availability.

About HP
HP Inc. (NYSE:HPQ) is a global technology leader redefining the Future of Work. Operating in more than 180 countries, HP delivers innovative and AI-powered devices, software, services and subscriptions that drive business growth and professional fulfillment. For more information, please visit: HP.com.

i Based on HP’s internal analysis of competitive laptop PCs with AMD, Intel, Apple, and Qualcomm processors and configurable discrete or internal graphics as of August 2026. Most capable local agentic laptop PC based on the highest available graphics memory (VRAM) capacity among compared systems. Higher VRAM capacity may support larger local AI models and execution of multiple local AI agents, depending on configuration, model size, software, and workload.
ii Autodesk, Revit, and 3ds Max are registered trademarks or trademarks of Autodesk, Inc., and/or its subsidiaries and/or affiliates in the USA and/or other countries. All other brand names, product names, or trademarks belong to their respective holders. 
iii Up to 81% (actual 81.8%) higher TDP compared to the ZBook Ultra G1a with a max TDP of 55W and ZBook Ultra G3a with a max TDP of 100W

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4db9b4ed-6a22-48b0-b0b9-05fd085163f7

CONTACT: Media Contacts
HP Media Relations: MediaRelations@hp.com
HP.com/go/newsroom

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.